Study

Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.

Study ID Alternative Stable ID Type
EGAS00001005437 Other

Study Description

This study contains omics data from patients from the Intellance-2 clinical trial, in which effectiveness of ABT414 in EGFR amplified recurrent glioblastoma patients was tested. Patients were randomly assigned to one of three arms: (1) standard of care treatement (TMZ or CCNU), (2) Only ABT414 and (3) ABT414 + (TMZ|CCNU)

Study Datasets 3 datasets.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001007943
Intellance-2: rRNA-minus RNA-seq
Illumina NovaSeq 6000 224
EGAD00001007944
Intellance-2: TruSight Tumor 170 panel based RNA-seq
222
EGAD00001007945
Intellance-2: TruSight Tumor 170 panel based DNA-seq
216

Who archives the data?

Publications

Citations

Retrieving...
Retrieving...
Retrieving...
Retrieving...